Dynavax Technologies

Dynavax Technologies

Biopharmaceutical company discovering and developing novel products to prevent and treat infectious diseases.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor investor investor investor investor investor investor investor

€0.0

round
investor

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
investor

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
investor

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
investor

€0.0

round
*

$3.9m

Post IPO Equity
Total Funding000k

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
USD2021202220232024202520262027
Revenues0000000000000000000000000000
% growth844 %64 %(68 %)19 %20 %16 %14 %
EBITDA0000000000000000000000000000
% EBITDA margin32 %41 %9 %16 %5 %9 %10 %
Profit0000000000000000000000000000
% profit margin17 %41 %(3 %)10 %(13 %)20 %27 %
EV0000000000000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000
R&D % of revenue7 %6 %24 %22 %---

Source: Company filings or news article, Equity research estimates

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo